{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:42:39Z","timestamp":1790613759235,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128401","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T01:13:17Z","timestamp":1772586797000},"page":"128401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Increasing HPV vaccine uptake using a \u201cstart at 9\u201dstrategy: A pilot program"],"prefix":"10.1016","volume":"78","author":[{"given":"Sarah","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Sisskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manika","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128401_bb0005","series-title":"red book: 2024\u20132027 report of the committee on infectious diseases","article-title":"Human papillomaviruses","author":"American Academy of Pediatrics. Committee on Infectious Diseases","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128401_bb0010","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.vaccine.2023.02.049","article-title":"Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States","volume":"41","author":"Clay","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128401_bb0015","author":"New York State Department of Health"},{"key":"10.1016\/j.vaccine.2026.128401_bb0020","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.2016.17615","article-title":"Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women","volume":"316","author":"Iversen","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2026.128401_bb0025","doi-asserted-by":"crossref","first-page":"2175541","DOI":"10.1080\/21645515.2023.2175541","article-title":"Optimizing timing of adolescent vaccines: impact of initiating HPV vaccination before Tdap or meningococcal vaccination on timely completion of the HPV vaccination series","volume":"19","author":"Kajtezovic","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0030","doi-asserted-by":"crossref","first-page":"2161253","DOI":"10.1080\/21645515.2022.2161253","article-title":"HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US","volume":"19","author":"Saxena","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2146434","article-title":"Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9","volume":"18","author":"O\u2019Leary","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0040","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/cncr.33574","article-title":"Updated American Cancer Society HPV vaccine guideline seeks to reinforce key messages: new recommendations emphasize the importance of routinely offering the vaccine at the ages of 9 to 12 years","volume":"127","author":"Printz","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.vaccine.2026.128401_bb0045","doi-asserted-by":"crossref","first-page":"2180250","DOI":"10.1080\/21645515.2023.2180250","article-title":"Implementing interventions to start HPV vaccination at age 9: using the evidence we have","volume":"19","author":"Brandt","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2172276","article-title":"Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10","volume":"19","author":"Kahn","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0055","doi-asserted-by":"crossref","first-page":"2480870","DOI":"10.1080\/21645515.2025.2480870","article-title":"Human papillomavirus vaccination at age 9 or 10 years to increase coverage \u2013 a narrative review of the literature, United States 2014-2024","volume":"21","author":"Brewer","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.acap.2018.05.005","article-title":"Quality improvement initiative to improve human papillomavirus vaccine initiation at 9 years of age","volume":"18","author":"Goleman","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2026.128401_bb0065","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2024.03.050","article-title":"Effect of age at initiation of the human papillomavirus on the association between race\/ethnicity and completion of the vaccine series","volume":"42","author":"Hirth","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128401_bb0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.acap.2022.01.008","article-title":"Recommending HPV vaccination at age 9: a national survey of primary care professionals","volume":"22","author":"Kong","year":"2022","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.vaccine.2026.128401_bb0075","doi-asserted-by":"crossref","first-page":"2181610","DOI":"10.1080\/21645515.2023.2181610","article-title":"HPV vaccine recommendations by age: a survey of providers in federally qualified health centers","volume":"19","author":"Lake","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0080","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-069625","article-title":"Feasibility and acceptability of recommending HPV vaccine at ages 9-10 years","volume":"156","author":"Tietbohl","year":"2025","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2026.128401_bb0085","doi-asserted-by":"crossref","first-page":"2213603","DOI":"10.1080\/21645515.2023.2213603","article-title":"Human papillomavirus vaccination at the first opportunity: an overview","volume":"19","author":"Bednarczyk","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0090","series-title":"Practice facilitation handbook content last reviewed","year":"2018"},{"key":"10.1016\/j.vaccine.2026.128401_bb0095","author":"The Guide to Community Preventive Services"},{"key":"10.1016\/j.vaccine.2026.128401_bb0100","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/vaccines11081390","article-title":"Recommended interventions to improve human papillomavirus vaccination uptake among adolescents: a review of quality improvement methodologies","volume":"11","author":"Khalid","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128401_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamapediatrics.2023.5070","article-title":"What health systems can do now to improve human papillomavirus vaccination","volume":"178","author":"Kelly","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2026.128401_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamapediatrics.2023.4932","article-title":"Multilevel implementation strategies for adolescent human papillomavirus vaccine uptake: a cluster randomized clinical trial","volume":"178","author":"Finney Rutten","year":"2024","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2026.128401_bb0115","article-title":"Effect of an HPV vaccination multi-level, multi-component program on HPV vaccination initiation and completion in a pediatric clinic network","volume":"12","author":"Savas","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128401_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pop.2020.05.008","article-title":"Establishing and maintaining a vaccine-positive practice culture","volume":"47","author":"Resic","year":"2020","journal-title":"Prim Care"},{"key":"10.1016\/j.vaccine.2026.128401_bb0125","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1016\/j.vaccine.2020.11.014","article-title":"A survey of office practice: parents, front office staff, nurses, and clinicians hold disparate views on adolescent vaccines","volume":"38","author":"Roberts","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128401_bb0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/JXX.0000000000000064","article-title":"Importance of a team approach to recommending the human papillomavirus vaccination","volume":"30","author":"Fontenot","year":"2018","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.vaccine.2026.128401_bb0135","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.3928\/19382359-20201115-02","article-title":"Strengthening vaccine confidence and acceptance in the pediatric provider office","volume":"49","author":"Mbaeyi","year":"2020","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.vaccine.2026.128401_bb0140","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1080\/21645515.2019.1627822","article-title":"A quality improvement education initiative to increase adolescent human papillomavirus (HPV) vaccine completion rates","volume":"15","author":"Bonville","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0145","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amepre.2017.03.022","article-title":"Impact of provider recommendation on Tdap vaccination of adolescents aged 13-17 years","volume":"53","author":"Lu","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2026.128401_bb0150","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.vaccine.2018.04.077","article-title":"Association between provider recommendation and influenza vaccination status among children","volume":"36","author":"Kahn","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128401_bb0155","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2016.01.061","article-title":"HPV vaccination coverage of teen girls: the influence of health care providers","volume":"34","author":"Smith","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128401_bb0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/1055-9965.EPI-16-0877","article-title":"A population-based study of sociodemographic and geographic variation in HPV vaccination","volume":"26","author":"Finney Rutten","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2026.128401_bb0165","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ypmed.2019.03.037","article-title":"Disparities and reverse disparities in HPV vaccination: a systematic review and meta-analysis","volume":"123","author":"Spencer","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2026.128401_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/21645515.2018.1512453","article-title":"Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature","volume":"15","author":"Hirth","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2487383","article-title":"Demographic disparities, temporal trends, and geographic patterns of HPV vaccination on Long Island, New York: a comprehensive analysis of immunization registry data (2012\u22122023)","volume":"21","author":"Ding","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0180","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/OLQ.0000000000001410","article-title":"Human papillomavirus vaccination trends and disparities in the United States: who is getting left behind?","volume":"48","author":"Chan","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2026.128401_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105902","article-title":"Exacerbating disparities?: cervical cancer screening and HPV vaccination","volume":"130","author":"Silver","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2026.128401_bb0190","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1158\/1055-9965.EPI-21-0307","article-title":"Reducing poverty-related disparities in cervical cancer: the role of HPV vaccination","volume":"30","author":"Spencer","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2026.128401_bb0195","doi-asserted-by":"crossref","first-page":"2178219","DOI":"10.1080\/21645515.2023.2178219","article-title":"Recommending HPV vaccination at age 9 to reduce health disparities: communication challenges and opportunities","volume":"19","author":"Coyne-Beasley","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128401_bb0200","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/vaccines11101623","article-title":"Association between religious beliefs and HPV vaccination attitudes among college students","volume":"21","author":"Hittson","year":"2023","journal-title":"Vaccines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26002094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:25:48Z","timestamp":1783376748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26002094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"alternative-id":["S0264410X26002094"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128401","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing HPV vaccine uptake using a \u201cstart at 9\u201dstrategy: A pilot program","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128401"}}